Concepedia
Statistics
Publications
3
Citations
139
H-Index
Active since
2014
Affiliations
University of Oxford(Current)
MRC Weatherall Institute of Molecular Medicine
John Radcliffe Hospital
Katharina Feldinger is an author at University of Oxford specializing in oncology, molecular oncology, and medicine.
Publications per year
2014–2024
ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer
Katharina Feldinger, Daniele Generali, Gabriela Krämer-Marek et al. · Oncotarget · 2014 · 88 citations · Full text
Medicine, Molecular Medicine, Oncology +16
Adaptation to HIF1α Deletion in Hypoxic Cancer Cells by Upregulation of GLUT14 and Creatine Metabolism
Alessandro Valli, Matteo Morotti, Christos E. Zois et al. · Molecular Cancer Research · 2019 · 30 citations · Full text
Medicine, Biochemistry, Oncology +17
Neratinib could be effective as monotherapy or in combination with trastuzumab in HER2-low breast cancer cells and organoid models
Maryam Arshad, Abul Kalam Azad, Phoebe Yuen Ka Chan et al. · British Journal of Cancer · 2024 · 21 citations · Full text
Medicine, Oncology, Pharmacology +17
1–3 of 3